Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines

Ina Patties1, Rolf-Dieter Kortmann, Annegret Glasow

  • 1Department of Radiation Therapy, University of Leipzig, Stephanstraße 9a, Leipzig, 04103, Germany. Ina.patties@medizin.uni-leipzig.de

Abstract

Insights

This study investigated combining 5-aza-2'-deoxycytidine (5-aza-dC) with other drugs to treat medulloblastoma (MB). While combinations reduced metabolic activity, they did not significantly impact long-term cancer cell survival in vitro.

Area of Science:

  • Oncology
  • Cancer Biology
  • Epigenetics

Background:

  • Medulloblastoma (MB) is a common childhood brain tumor with poor survival rates.
  • Previous research indicated 5-aza-2 -deoxycytidine (5-aza-dC) reduces MB cell survival.
  • This study aimed to enhance MB therapy by combining 5-aza-dC with other epigenetic and differentiation drugs.

Purpose of the Study:

  • To evaluate the combinatorial effects of 5-aza-dC with epigenetic drugs (valproic acid, SAHA) and differentiation-inducing drugs (resveratrol, abacavir, retinoic acid) on human MB cells in vitro.
  • To determine if these combinations could intensify antitumor therapy against medulloblastoma.

Main Methods:

  • Three human MB cell lines were treated with 5-aza-dC alone or in combination for 3 or 6 days.
  • Metabolic activity was assessed using WST-1 assay.
  • Clonogenic assays measured long-term reproductive survival, and γH2AX assays detected DNA double-strand break induction.

Main Results:

  • Most single drugs, except ATRA, reduced metabolic activity dose-dependently.
  • 5-aza-dC combined with resveratrol showed the most significant reduction in metabolic activity across all cell lines.
  • While 5-aza-dC alone reduced clonogenicity and induced DNA damage, adding resveratrol did not enhance these effects.

Conclusions:

  • Combinatorial treatment with 5-aza-dC and resveratrol significantly decreased metabolic activity but did not translate to reduced long-term survival in vitro.
  • Further in vivo studies are necessary to understand resveratrol's anticancer mechanisms against medulloblastoma.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...